{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T05:24:14Z","timestamp":1784957054842,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.canlet.2022.215778","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T11:37:56Z","timestamp":1655120276000},"page":"215778","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Down-regulation of circPTTG1IP induces hepatocellular carcinoma development via miR-16-5p\/RNF125\/JAK1 axis"],"prefix":"10.1016","volume":"543","author":[{"given":"Rui","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-Bing","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-song","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao-qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren-jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-qing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-jie","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8032-7959","authenticated-orcid":false,"given":"Dou-sheng","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2022.215778_bib1","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.canlet.2022.215778_bib2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41571-018-0073-4","article-title":"Molecular therapies and precision medicine for hepatocellular carcinoma","volume":"15","author":"Llovet","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2022.215778_bib3","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41392-020-00264-x","article-title":"Targeted therapy for hepatocellular carcinoma","volume":"5","author":"Huang","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2022.215778_bib4","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","article-title":"The biogenesis, biology and characterization of circular RNAs","volume":"20","author":"Kristensen","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.canlet.2022.215778_bib5","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature11993","article-title":"Natural RNA circles function as efficient microRNA sponges","volume":"495","author":"Hansen","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2022.215778_bib6","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nsmb.2959","article-title":"Exon-intron circular RNAs regulate transcription in the nucleus","volume":"22","author":"Li","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.canlet.2022.215778_bib7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12943-019-1031-1","article-title":"Circular RNA circTRIM33-12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progression","volume":"18","author":"Zhang","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2022.215778_bib8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12943-020-01213-6","article-title":"Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p\/snail\/DPP4 axis","volume":"19","author":"Huang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2022.215778_bib9","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc3355","article-title":"Tumorigenesis in Down's syndrome: big lessons from a small chromosome","volume":"12","author":"Ni\u017eeti\u0107","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2022.215778_bib10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(99)05264-2","article-title":"Risks of leukaemia and solid tumours in individuals with Down's syndrome","volume":"355","author":"Hasle","year":"2000","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.canlet.2022.215778_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-019-0143-7","article-title":"Down syndrome","volume":"6","author":"Antonarakis","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.canlet.2022.215778_bib12","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1053\/j.gastro.2017.05.045","article-title":"Regulator of calcineurin 1 gene isoform 4, down-regulated in hepatocellular carcinoma, prevents proliferation, migration, and invasive activity of cancer cells and metastasis of orthotopic tumors by inhibiting nuclear translocation of NFAT1","volume":"153","author":"Jin","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2022.215778_bib13","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.2147\/OTT.S269606","article-title":"RNF128 promotes malignant behaviors via EGFR\/MEK\/ERK pathway in hepatocellular carcinoma","volume":"13","author":"Bai","year":"2020","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.canlet.2022.215778_bib14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13046-019-1113-3","article-title":"Overexpression of RNF38 facilitates TGF-\u03b2 signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinoma","volume":"38","author":"Peng","year":"2019","journal-title":"J. Exp. Clin. Cancer Res. : CR"},{"key":"10.1016\/j.canlet.2022.215778_bib15","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.celrep.2015.04.049","article-title":"Downregulation of the ubiquitin ligase RNF125 underlies resistance of melanoma cells to BRAF inhibitors via JAK1 deregulation","volume":"11","author":"Kim","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2022.215778_bib16","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1349-7006.2008.00725.x","article-title":"Orthotopic implantation mouse model and cDNA microarray analysis indicates several genes potentially involved in lymph node metastasis of colorectal cancer","volume":"99","author":"Sasaki","year":"2008","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2022.215778_bib17","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.chom.2019.02.013","article-title":"NLRP12 regulates anti-viral RIG-I activation via interaction with TRIM25","volume":"25","author":"Chen","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.canlet.2022.215778_bib18","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.4049\/jimmunol.1601322","article-title":"The ubiquitin ligase RNF125 targets innate immune adaptor protein TRIM14 for ubiquitination and degradation","volume":"198","author":"Jia","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2022.215778_bib19","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.3389\/fimmu.2020.01296","article-title":"Recent advances and contradictions in the study of the individual roles of ubiquitin ligases that regulate RIG-I-like receptor-mediated antiviral innate immune responses","volume":"11","author":"Oshiumi","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2022.215778_bib20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/hep.24623","article-title":"Association of gene expression involving innate immunity and genetic variation in interleukin 28B with antiviral response","volume":"55","author":"Asahina","year":"2012","journal-title":"Hepatology (Baltimore, Md"},{"key":"10.1016\/j.canlet.2022.215778_bib21","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000481210","article-title":"E3 ubiquitin ligase RNF125 activates interleukin-36 receptor signaling and contributes to its turnover","volume":"10","author":"Saha","year":"2018","journal-title":"Journal of innate immunity"},{"key":"10.1016\/j.canlet.2022.215778_bib22","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20182091","article-title":"Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia","volume":"217","author":"Tang","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2022.215778_bib23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1001\/jama.2019.9055","article-title":"Effect of filgotinib vs placebo on clinical response in patients with moderate to severe rheumatoid arthritis refractory to disease-modifying antirheumatic drug therapy: the FINCH 2 randomized clinical trial","volume":"322","author":"Genovese","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.canlet.2022.215778_bib24","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0140-6736(16)32537-5","article-title":"Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial","volume":"389","author":"Vermeire","year":"2017","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.canlet.2022.215778_bib25","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/annrheumdis-2020-219213","article-title":"Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial","volume":"80","author":"Westhovens","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.canlet.2022.215778_bib26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2022.215778_bib27","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1038\/s41467-018-06318-7","article-title":"Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations","volume":"9","author":"MacParland","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2022.215778_bib28","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature11928","article-title":"Circular RNAs are a large class of animal RNAs with regulatory potency","volume":"495","author":"Memczak","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2022.215778_bib29","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jhep.2018.01.012","article-title":"Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma","volume":"68","author":"Yu","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2022.215778_bib30","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/hep.31068","article-title":"Circular RNA sequencing identifies CircASAP1 as a key regulator in hepatocellular carcinoma metastasis","volume":"72","author":"Hu","year":"2020","journal-title":"Hepatology (Baltimore, Md"},{"key":"10.1016\/j.canlet.2022.215778_bib31","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3389\/fgene.2015.00223","article-title":"The genetics of folate metabolism and maternal risk of birth of a child with Down syndrome and associated congenital heart defects","volume":"6","author":"Copped\u00e8","year":"2015","journal-title":"Front. Genet."},{"key":"10.1016\/j.canlet.2022.215778_bib32","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ccell.2016.12.004","article-title":"Single-chromosome gains commonly function as tumor suppressors","volume":"31","author":"Sheltzer","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2022.215778_bib33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41568-020-00321-1","article-title":"Aneuploidy as a promoter and suppressor of malignant growth","volume":"21","author":"Vasudevan","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2022.215778_bib34","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1186\/s12885-017-3694-6","article-title":"PTTG1-interacting protein (PTTG1IP\/PBF) predicts breast cancer survival","volume":"17","author":"Repo","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2022.215778_bib35","doi-asserted-by":"crossref","first-page":"5863","DOI":"10.1158\/0008-5472.CAN-18-0855","article-title":"PTTG and PBF functionally interact with p53 and predict overall survival in head and neck cancer","volume":"78","author":"Read","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2022.215778_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101857","article-title":"Super-enhancer LncRNA LINC00162 promotes progression of bladder cancer","volume":"23","author":"Wang","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.canlet.2022.215778_bib37","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4149\/gpb_2021014","article-title":"circ-PTTG1IP\/miR-671-5p\/TLR4 axis regulates proliferation, migration, invasion and inflammatory response of fibroblast-like synoviocytes in rheumatoid arthritis","volume":"40","author":"Chen","year":"2021","journal-title":"Gen. Physiol. Biophys."},{"key":"10.1016\/j.canlet.2022.215778_bib38","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41408-020-00344-9","article-title":"In vitro and ex vivo gene expression profiling reveals differential kinetic response of HSPs and UPR genes is associated with PI resistance in multiple myeloma","volume":"10","author":"Mitra","year":"2020","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.canlet.2022.215778_bib39","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1158\/1078-0432.CCR-14-2566","article-title":"A miRNA-based signature detected in primary melanoma tissue predicts development of brain metastasis","volume":"21","author":"Hanniford","year":"2015","journal-title":"Clin. Cancer Res. : an official journal of the American Association for Cancer Research"},{"key":"10.1016\/j.canlet.2022.215778_bib40","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s13046-019-1188-x","article-title":"Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma","volume":"38","author":"Liu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res. : CR"},{"key":"10.1016\/j.canlet.2022.215778_bib41","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1476-4598-6-60","article-title":"OncomiRs: the discovery and progress of microRNAs in cancers","volume":"6","author":"Cho","year":"2007","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2022.215778_bib42","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1126\/science.1071545","article-title":"A road map for those who don't know JAK-STAT","volume":"296","author":"Aaronson","year":"2002","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.canlet.2022.215778_bib43","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.cell.2020.11.041","article-title":"Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma","volume":"184","author":"Sun","year":"2021","journal-title":"Cell"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383522002622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383522002622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T16:04:14Z","timestamp":1759593854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383522002622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":43,"alternative-id":["S0304383522002622"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2022.215778","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Down-regulation of circPTTG1IP induces hepatocellular carcinoma development via miR-16-5p\/RNF125\/JAK1 axis","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2022.215778","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"215778"}}